NASDAQ: KROS

A closer look at KROS’s price-to-free cash flow ratio
Cameron Mitchell
In the current trading session, Keros Therapeutics Inc’s (KROS) stock is trading at the price of $21.3, a fall of ...

Introducing Our Rant Against Keros Therapeutics Inc
Arcelia Reed
Keros Therapeutics Inc (KROS)’s stock has witnessed a price hike of 0.37% from the previous close with its current price ...

KROS’s price-to-free cash flow ratio: A closer look at its relevance
Cameron Mitchell
Keros Therapeutics Inc (KROS)’s stock has witnessed a price hike of 1.84% from the previous close with its current price ...





